JORDAN LAWSON: Open Payments
NPI 1609557800 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 39 payments from 18 companies in 2025. Trend: 2023 $45 · 2024 $1,467 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 6 | $146 |
| Calliditas Therapeutics US Inc. | 3 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Novo Nordisk Inc | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Philips North America LLC | 2 | $52 |
| Boston Scientific Corporation | 2 | $51 |
| Vifor Pharma, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: TARPEYO, Kerendia, Rivfloza, Ambulatory Monitoring & Diagnostics Undivided, Veltassa, JYNARQUE, LOKELMA, LEQVIO.
Industry payments across SC — which companies pay providers there.
